Rekvina Laboratories Limited (VINRKLB) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE092O01028
₹50.74+0.99 (+1.99%)
Key metrics
- Market Cap
- ₹56 Cr
- P/E Ratio
- —
- EPS
- -0.56
- Book Value
- -2.04
- P/B Ratio
- —
- ROE
- 20.74%
- ROCE
- -104.17%
- Debt / Equity
- -1.2
- Net Margin
- -20.13%
- Revenue Growth
- —
- Profit Growth
- -85.78%
- Dividend Yield
- —
- 52W High
- ₹50.74
- 52W Low
- ₹4.50
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Rekvina Laboratories Limited
Rekvina Laboratories Limited engages in manufacturing and marketing pharmaceutical products in India. It offers pharmaceutical formulations. The company also provides contract research and manufacturing services. Rekvina Laboratories Limited was incorporated in 1988 and is based in Vadodara, India.
- Headquarters
- Vadodara, India
- Promoter Holding
- 99.15%
The full Rekvina Laboratories Limited analysis
Create a free account to open the complete VINRKLB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.